Joss RA - Search Results

1

Effect of thoracic radiotherapy on mortality in limited small cell lung cancer. A meta-analysis of 13 randomized trials among 2,140 patients.

Arriagada R, Pignon JP, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al. Arriagada R, et al. Among authors: joss ra. Anticancer Res. 1994 Jan-Feb;14(1B):333-5. Anticancer Res. 1994. PMID: 8166478

2

A meta-analysis of thoracic radiotherapy for small-cell lung cancer.

Pignon JP, Arriagada R, Ihde DC, Johnson DH, Perry MC, Souhami RL, Brodin O, Joss RA, Kies MS, Lebeau B, et al. Pignon JP, et al. Among authors: joss ra. N Engl J Med. 1992 Dec 3;327(23):1618-24. doi: 10.1056/NEJM199212033272302. N Engl J Med. 1992. PMID: 1331787 Free article.

3

Unexpected high toxicity in a phase II study of teniposide (VM-26) in elderly patients with untreated small cell lung cancer (SCLC).

Cerny T, Pedrazzini A, Joss RA, Brunner KW. Cerny T, et al. Among authors: joss ra. Eur J Cancer Clin Oncol. 1988 Nov;24(11):1791-4. doi: 10.1016/0277-5379(88)90083-1. Eur J Cancer Clin Oncol. 1988. PMID: 2850194

4

Should maintenance chemotherapy be used to treat small cell lung cancer?

Sculier JP, Joss RA, Schefer H, Hirsch FR, Hansen HH. Sculier JP, et al. Among authors: joss ra. Eur J Cancer. 1998 Jul;34(8):1148-55. doi: 10.1016/s0959-8049(98)00081-1. Eur J Cancer. 1998. PMID: 9849472 Review. No abstract available.

5

Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK).

Joss RA, Alberto P, Bleher EA, Ludwig C, Siegenthaler P, Martinelli G, Sauter C, Schatzmann E, Senn HJ. Joss RA, et al. Ann Oncol. 1994 Dec;5(10):921-8. doi: 10.1093/oxfordjournals.annonc.a058731. Ann Oncol. 1994. PMID: 7696164 Free article. Clinical Trial.

6

Adjuvant therapy of lung cancer.

Joss RA, Brand B. Joss RA, et al. Helv Chir Acta. 1990 Jan;56(5):735-47. Helv Chir Acta. 1990. PMID: 2157687 Review.

7

A randomized trial of the four most active regimens for metastatic non-small-cell lung cancer.

Ruckdeschel JC, Finkelstein DM, Ettinger DS, Creech RH, Mason BA, Joss RA, Vogl S. Ruckdeschel JC, et al. Among authors: joss ra. J Clin Oncol. 1986 Jan;4(1):14-22. doi: 10.1200/JCO.1986.4.1.14. J Clin Oncol. 1986. PMID: 3510278 Clinical Trial.

8

Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK.

Hürny C, Bernhard J, Joss R, Willems Y, Cavalli F, Kiser J, Brunner K, Favre S, Alberto P, Glaus A, et al. Hürny C, et al. Ann Oncol. 1992 Dec;3(10):825-31. doi: 10.1093/oxfordjournals.annonc.a058104. Ann Oncol. 1992. PMID: 1337466 Free article. Clinical Trial.

9

Etoposide, cisplatin and doxorubicin in patients with small cell lung cancer: tumor response and long term survival.

Alberto P, Mermillod B, Joss R, Obrecht JP, Martz G, Kaplan S, Cavalli F. Alberto P, et al. Eur J Cancer Clin Oncol. 1986 Jun;22(6):701-8. doi: 10.1016/0277-5379(86)90169-0. Eur J Cancer Clin Oncol. 1986. PMID: 3017722

10

"Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK).

Hürny C, Bernhard J, Joss R, Schatzmann E, Cavalli F, Brunner K, Alberto P, Senn HJ, Metzger U. Hürny C, et al. Support Care Cancer. 1993 Nov;1(6):316-20. doi: 10.1007/BF00364969. Support Care Cancer. 1993. PMID: 8156249 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

120 results

Search Page

Filters